Literature DB >> 22971780

HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.

Brandon L Guthrie1, Barbara Lohman-Payne, Amy Y Liu, Rose Bosire, Samuel Victor Nuvor, Robert Y Choi, Romel D Mackelprang, James N Kiarie, Stephen C De Rosa, Barbra A Richardson, Grace C John-Stewart, Carey Farquhar.   

Abstract

A number of studies of highly exposed HIV-1-seronegative individuals (HESN) have found HIV-1-specific cellular responses. However, there is limited evidence that responses prevent infection or are linked to HIV-1 exposure. Peripheral blood mononuclear cells (PBMC) were isolated from HESN in HIV-1-discordant relationships and low-risk controls in Nairobi, Kenya. HIV-1-specific responses were detected using gamma interferon (IFN-γ) enzyme-linked immunosorbent spot (ELISpot) assays stimulated by peptide pools spanning the subtype A HIV-1 genome. The HIV-1 incidence in this HESN cohort was 1.5 per 100 person years. Positive ELISpot responses were found in 34 (10%) of 331 HESN and 14 (13%) of 107 low-risk controls (odds ratio [OR] = 0.76; P = 0.476). The median immunodominant response was 18.9 spot-forming units (SFU)/10(6) peripheral blood mononuclear cells (PBMC). Among HESN, increasing age (OR = 1.24 per 5 years; P = 0.026) and longer cohabitation with the HIV-1-infected partner (OR = 5.88 per 5 years; P = 0.003) were associated with responses. These factors were not associated with responses in controls. Other exposure indicators, including the partner's HIV-1 load (OR = 0.99 per log(10) copy/ml; P = 0.974) and CD4 count (OR = 1.09 per 100 cells/μl; P = 0.238), were not associated with responses in HESN. HIV-1-specific cellular responses may be less relevant to resistance to infection among HESN who are using risk reduction strategies that decrease their direct viral exposure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22971780      PMCID: PMC3491560          DOI: 10.1128/CVI.00179-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  53 in total

1.  New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; K Fowke; T Dong; P Kiama; J Rutherford; E Njagi; F Mwangi; T Rostron; J Onyango; J Oyugi; K S MacDonald; J J Bwayo; F A Plummer
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

2.  T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV.

Authors:  M Clerici; M Saresella; F Colombo; S Fossati; N Sala; D Bricalli; M L Villa; P Ferrante; L Dally; A Vigano'
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

3.  Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women.

Authors:  Barbara L Shacklett; Robert E Means; Marie Larsson; David T Wilkens; Thomas J Beadle; Melissa J Merritt; Nina Bhardwaj; Paul E Palumbo; Joan H Skurnick; Donald B Louria; Douglas F Nixon
Journal:  AIDS Res Hum Retroviruses       Date:  2002-07-20       Impact factor: 2.205

4.  Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples.

Authors:  Dana DeVange Panteleeff; Sandra Emery; Barbra A Richardson; Christine Rousseau; Sarah Benki; Sharon Bodrug; Joan K Kreiss; Julie Overbaugh
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner.

Authors:  Nattawan Promadej; Caroline Costello; Mary M Wernett; Prasad S Kulkarni; Valerie A Robison; Kenrad E Nelson; Thomas W Hodge; Vinai Suriyanon; Ann Duerr; Janet M McNicholl
Journal:  J Infect Dis       Date:  2003-03-19       Impact factor: 5.226

6.  Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners.

Authors:  D Bienzle; K S MacDonald; F M Smaill; C Kovacs; M Baqi; B Courssaris; M A Luscher; S L Walmsley; K L Rosenthal
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

7.  Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.

Authors:  Joan H Skurnick; Paul Palumbo; Anthony DeVico; Barbara L Shacklett; Fred T Valentine; Michael Merges; Roberta Kamin-Lewis; Jiri Mestecky; Thomas Denny; George K Lewis; Joan Lloyd; Robert Praschunus; Amanda Baker; Douglas F Nixon; Sharon Stranford; Robert Gallo; Sten H Vermund; Donald B Louria
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

8.  Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals.

Authors:  Anthony Kebba; Pontiano Kaleebu; Samantha Rowland; Rebecca Ingram; Jimmy Whitworth; Nesrina Imami; Frances Gotch
Journal:  J Infect Dis       Date:  2004-04-19       Impact factor: 5.226

9.  HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans.

Authors:  Anthony Kebba; Pontiano Kaleebu; Jennifer Serwanga; Samantha Rowland; David Yirrell; Robert Downing; Jill Gilmour; Nesrina Imami; Frances Gotch; Jimmy Whitworth
Journal:  AIDS Res Hum Retroviruses       Date:  2004-01       Impact factor: 2.205

10.  Detection of antigen-specific T cell interferon gamma expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques.

Authors:  Bapi Pahar; Jun Li; Tracy Rourke; Christopher J Miller; Michael B McChesney
Journal:  J Immunol Methods       Date:  2003-11       Impact factor: 2.303

View more
  8 in total

1.  A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection.

Authors:  Anna Månberg; Frideborg Bradley; Ulrika Qundos; Brandon L Guthrie; Kenzie Birse; Laura Noël-Romas; Cecilia Lindskog; Rose Bosire; James Kiarie; Carey Farquhar; Adam D Burgener; Peter Nilsson; Kristina Broliden
Journal:  Mol Cell Proteomics       Date:  2018-11-30       Impact factor: 5.911

2.  Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.

Authors:  Brandon L Guthrie; Andrea Introini; Alison C Roxby; Robert Y Choi; Rose Bosire; Barbara Lohman-Payne; Taha Hirbod; Carey Farquhar; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

3.  Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.

Authors:  Jason Soh; Anne F Rositch; Laura Koutsky; Brandon L Guthrie; Robert Y Choi; Rose K Bosire; Ann Gatuguta; Jennifer S Smith; James Kiarie; Barbara Lohman-Payne; Carey Farquhar
Journal:  Int J STD AIDS       Date:  2013-09-18       Impact factor: 1.359

4.  Incident HSV-2 infections are common among HIV-1-discordant couples.

Authors:  Anthony N Muiru; Brandon L Guthrie; Rose Bosire; Michele Merkel; Amy Y Liu; Robert Y Choi; Barbara Lohman-Payne; Ann Gatuguta; Romel D Mackelprang; James N Kiarie; Carey Farquhar
Journal:  J Infect Dis       Date:  2013-07-09       Impact factor: 5.226

5.  Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates.

Authors:  María Julia Ruiz; Jimena Salido; Lorena Abusamra; Yanina Ghiglione; Cintia Cevallos; Gabriel Damilano; Ana María Rodriguez; César Trifone; Natalia Laufer; Luis D Giavedoni; Omar Sued; Horacio Salomón; María Magdalena Gherardi; Gabriela Turk
Journal:  EBioMedicine       Date:  2017-11-03       Impact factor: 8.143

6.  Low HDL-cholesterol among HIV-1 infected and HIV-1 uninfected individuals in Nairobi, Kenya.

Authors:  Anne Njoroge; B L Guthrie; Rose Bosire; Mark Wener; James Kiarie; Carey Farquhar
Journal:  Lipids Health Dis       Date:  2017-06-09       Impact factor: 3.876

7.  Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices.

Authors:  Kenzie D Birse; Laura M Romas; Brandon L Guthrie; Peter Nilsson; Rose Bosire; James Kiarie; Carey Farquhar; Kristina Broliden; Adam D Burgener
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

8.  High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.

Authors:  Amy Y Liu; Stephen C De Rosa; Brandon L Guthrie; Robert Y Choi; Rose Kerubo-Bosire; Barbra A Richardson; James Kiarie; Carey Farquhar; Barbara Lohman-Payne
Journal:  Immun Inflamm Dis       Date:  2018-07-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.